Mr. John Gevisser reports

MEDX HEALTH CORP. NAMES MEGHAN GEARY AS SENIOR VICE PRESIDENT OF OPERATIONS

MedX Health Corp. has confirmed the appointment of Meghan Geary as the company's senior vice-president of operations, effective immediately.

With over 10 years experience in building scalable programs across software-as-a-service and high-growth health care companies, Ms. Geary will oversee strategic operations, drive organization performance and support MedX's continued growth trajectory.

"I'm excited to join MedX at such a pivotal stage of its journey," said Ms. Geary. "Throughout my career, I've focused on scaling programs that streamline processes and promote cross-functional alignment. I look forward to collaborating with the MedX team to optimize operations and ensure the company is positioned for long-term success."

The company's chief executive officer, John Gevisser, added: "Meghan brings formidable experience to MedX at a time when we are scaling operations across different markets. Having previously worked closely with her, I understand what a vital asset to our team she is. Her ability to lead strategic programs, adjust and direct processes, and improve organizational performance will play a central role in our next phase of growth. Meghan critically understands that our deep and dynamic image store is central to our AI and SaaS strategy."

About MedX Health Corp.

MedX Health, headquartered in Ontario, Canada, is a leader in non-invasive skin assessment and teledermatology. Its proprietary SIAscopy technology, integrated into the DermSecure platform, enables pain-free, accurate imaging of skin lesions for rapid dermatologist review. These products are cleared for use in 38 countries including by Health Canada, the U.S. Food and Drug Administration, the Therapeutic Goods Administration, and Conformite Europeenne for use in Canada, the United States, Australia, New Zealand, the United Kingdom, the European Union and Turkey. MedX's advanced telemedicine platform enables health care professionals to quickly and accurately assess suspicious moles, lesions and other skin conditions through its proprietary imaging technology, SIAscopy, and its secure, cloud-based patient management system, DermSecure. SIAscopy is the only technology capable of capturing five high-resolution images, including four spectrophotometric scans that penetrate two millimetres below the skin's surface.

We seek Safe Harbor.